Haemovigilance is the systematic surveillance of transfusion-related adverse events (AE) and reactions (AR), encompassing the entire transfusion chain and aimed at improving the safety of the transfusion process. A haemovigilance system is an integral part of quality management in a blood system and is essential for the continual improvement of the quality and safety of blood products and to increase the safety, efficacy and efficiency of blood transfusion. It encompasses all activities of the blood transfusion chain, vein-to-vein, from blood donor to transfused patient.
Disclaimer – This page is provided to provide members with useful information, not ISBT endorsement of the guidance within the linked sites.
